ID: ALA19443

Max Phase: Preclinical

Molecular Formula: C22H29N3NaO5P

Molecular Weight: 447.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)CC(NC(Cc1ccccc1)NP(=O)([O-])CNC(=O)c1ccccc1)C(=O)O.[Na+]

Standard InChI:  InChI=1S/C22H30N3O5P.Na/c1-16(2)13-19(22(27)28)24-20(14-17-9-5-3-6-10-17)25-31(29,30)15-23-21(26)18-11-7-4-8-12-18;/h3-12,16,19-20,24H,13-15H2,1-2H3,(H,23,26)(H,27,28)(H2,25,29,30);/q;+1/p-1

Standard InChI Key:  CUEZVGSSYRNSJX-UHFFFAOYSA-M

Associated Targets(Human)

Angiotensin-converting enzyme 1423 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Neprilysin 537 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Angiotensin-converting enzyme-related carboxypeptidase 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 447.47Molecular Weight (Monoisotopic): 447.1923AlogP: 2.81#Rotatable Bonds: 12
Polar Surface Area: 127.76Molecular Species: ZWITTERIONHBA: 4HBD: 5
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.81CX Basic pKa: 9.52CX LogP: 0.60CX LogD: -2.21
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.25Np Likeness Score: -0.05

References

1. Elliott RL, Marks N, Berg MJ, Portoghese PS..  (1985)  Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.,  28  (9): [PMID:2993614] [10.1021/jm00147a015]

Source